[1]
2025. Ki-67 Index and Somatostatin Receptor Expression as Prognostic Markers in Patients with Pancreatic Neuroendocrine Tumours: A Review. Annals of Gastroenterology and Digestive Disorders. 8, 1 (Jul. 2025), 5–9. DOI:https://doi.org/10.5281/zenodo.22202865.